FI803704L - En heterocyklisk foerening och dess syntes farmaceutiska kompositioner innehaollande den och anvaendning av foereningarna och kompositionerna i medicin - Google Patents

En heterocyklisk foerening och dess syntes farmaceutiska kompositioner innehaollande den och anvaendning av foereningarna och kompositionerna i medicin

Info

Publication number
FI803704L
FI803704L FI803704A FI803704A FI803704L FI 803704 L FI803704 L FI 803704L FI 803704 A FI803704 A FI 803704A FI 803704 A FI803704 A FI 803704A FI 803704 L FI803704 L FI 803704L
Authority
FI
Finland
Prior art keywords
och
heterocyclisk
foereningarna
compositionerna
syntes
Prior art date
Application number
FI803704A
Other languages
English (en)
Finnish (fi)
Other versions
FI803704A7 (fi
Inventor
Jr Gordon Lewis Hodgson
Thomas Kevin Shumaker
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI803704A7 publication Critical patent/FI803704A7/fi
Publication of FI803704L publication Critical patent/FI803704L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI803704A 1979-11-30 1980-11-28 En heterocyklisk foerening och dess syntes farmaceutiska kompositioner innehaollande den och anvaendning av foereningarna och kompositionerna i medicin FI803704L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7941409 1979-11-30

Publications (2)

Publication Number Publication Date
FI803704A7 FI803704A7 (fi) 1981-05-31
FI803704L true FI803704L (fi) 1981-05-31

Family

ID=10509524

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803704A FI803704L (fi) 1979-11-30 1980-11-28 En heterocyklisk foerening och dess syntes farmaceutiska kompositioner innehaollande den och anvaendning av foereningarna och kompositionerna i medicin

Country Status (18)

Country Link
US (1) US4366158A (de)
EP (1) EP0030023A3 (de)
JP (1) JPS5699475A (de)
KR (1) KR830004293A (de)
AR (1) AR228442A1 (de)
AT (1) AT375363B (de)
AU (1) AU6495080A (de)
CA (1) CA1156235A (de)
DK (1) DK506480A (de)
ES (1) ES8203882A1 (de)
FI (1) FI803704L (de)
GB (1) GB2063868B (de)
GR (1) GR71918B (de)
HU (1) HU185224B (de)
IL (1) IL61580A (de)
IT (1) IT1221040B (de)
NZ (1) NZ195688A (de)
ZA (1) ZA807467B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1558582B1 (de) 2003-07-22 2005-12-21 Arena Pharmaceuticals, Inc. Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
GB0507198D0 (en) * 2005-04-08 2005-05-18 Sb Pharmco Inc Process for preparing bicyclic compounds
GB0519758D0 (en) * 2005-09-28 2005-11-09 Glaxo Group Ltd Novel process
EP2254564A1 (de) 2007-12-12 2010-12-01 Glaxo Group Limited Kombinationen mit 3-phenylsulfonyl-8-piperazinyl-1yl-chinolin
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
HK1245660A1 (zh) 2015-06-12 2018-08-31 Axovant Sciences Gmbh 有用於预防和治疗rem睡眠行为障碍的二芳基脲和芳基脲衍生物
WO2017011767A2 (en) 2015-07-15 2017-01-19 Axovant Sciences Ltd. Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

Also Published As

Publication number Publication date
FI803704A7 (fi) 1981-05-31
EP0030023A3 (de) 1981-09-02
GB2063868A (en) 1981-06-10
ATA582780A (de) 1983-12-15
KR830004293A (ko) 1983-07-09
ES497242A0 (es) 1982-04-01
IL61580A (en) 1984-06-29
GB2063868B (en) 1984-02-29
ZA807467B (en) 1982-07-28
AR228442A1 (es) 1983-03-15
AU6495080A (en) 1981-06-04
EP0030023A2 (de) 1981-06-10
IT8050277A0 (it) 1980-11-28
AT375363B (de) 1984-07-25
GR71918B (de) 1983-08-17
US4366158A (en) 1982-12-28
CA1156235A (en) 1983-11-01
NZ195688A (en) 1984-09-28
ES8203882A1 (es) 1982-04-01
DK506480A (da) 1981-05-31
IT1221040B (it) 1990-06-21
IL61580A0 (en) 1980-12-31
HU185224B (en) 1984-12-28
JPS5699475A (en) 1981-08-10

Similar Documents

Publication Publication Date Title
FI803037A7 (fi) Foerfarande foer framstaellning av en vattenhaltig loesning anvaendbar i medicin och kosmetik
BE872319A (fr) Composition pharmaceutique
FI800006A7 (fi) Anordning foer utnyttjande av den uppvaermda tryckvaetskan i arbetshydrauliken i ett motorfordon
BR8003522A (pt) Composicao inseticida
DK312279A (da) Farmaceutisk formulering af guargummi
IT1193847B (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline
FI803736L (fi) Ergolin-derivat foerfarande foer deras framstaellning och terapeutisk komposition
IT1095377B (it) Composizione farmaceutica
FI802324A7 (fi) Komposition foer attrahering av ambrosiaskalbaggar
IT7849938A0 (it) Composizioni farmaceutiche
SE7806441L (sv) Lekemedelskomposition
DK461579A (da) Farmeceutisk komposition indeholdende en aryltrifluorethanol
FI782169A7 (fi) Anordning foer byggande och foer reparerande av den eldfasta beklaednaden i industriella ugnar och upphettade kaerl
IT1134039B (it) Composizione farmaceutica ad azione prolungata
FI803483L (fi) Makrolidantibiotika foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner
FI790958A7 (fi) Anordning foer sidledes vikning av den tillplattade paofyllningsaendan av fyllda storsaeckar och foer framstaellning av tillslutare foer saeckarna
IT1118900B (it) Composizione farmaceutica contenente cefalosporina per somministrazione rettale
IT8148776A0 (it) Composti eterociclici loro preparazione e composizione farmaceutiche contenenti questi composti
SE7809810L (sv) Oral komposition
FI790548A7 (fi) Anordning foer framstaellning och reparering av den eldfasta fodringen i industriugnar
FI781507A7 (fi) Farmaceutiska kompositioner
FI801420A7 (fi) Laekemedelspreparat foer behandling av kraeftsvulster och foerfarande foer framstaellning av detta
IT1118828B (it) Composti e composizioni farmaceutiche ad azione mucolitica
SE7813062L (sv) Farmaceutisk komposition
IT7951182A0 (it) Antibiotico bn-183b,procedimento per produrlo e composizioni farmaceutiche che lo contengono

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: THE WELLCOME FOUNDATION LIMITED